| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
9,059,070 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Robinson Jim |
VP,Technical & Qual. Operation |
• – – |
2007-08-21 |
4 |
B |
$3.11 |
$62,369 |
D/D |
20,000 |
55,000 |
2.74 |
- |
|
| Robinson Jim |
VP, Technical & Quality Oper.O |
• – – |
2007-08-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,080 |
|
- |
|
| Robinson Jim |
VP, Technical & Quality Oper.O |
• – – |
2007-08-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,000 |
|
- |
|
| Heaton Penny |
Chief Medical OfficerOfficer |
• – – |
2007-08-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| Lambert John A |
Director |
– • – |
2007-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| Hall Patricia |
Chief Accounting Officer |
• – – |
2006-10-31 |
4 |
D |
$4.41 |
$33,075 |
D/D |
(7,500) |
13,514 |
|
- |
|
| Hall Patricia |
Chief Accounting Officer |
• – – |
2006-10-31 |
4 |
A |
$3.98 |
$29,850 |
D/D |
7,500 |
21,014 |
|
- |
|
| Hall Patricia |
Chief Accounting Officer |
• – – |
2006-10-30 |
4 |
D |
$4.09 |
$52,111 |
D/D |
(12,750) |
13,514 |
|
- |
|
| Hall Patricia |
Chief Accounting Officer |
• – – |
2006-10-30 |
4 |
A |
$1.34 |
$17,610 |
D/D |
12,750 |
17,264 |
|
- |
|
| Church Jeffrey Wayne |
VP, CFO and TreasurerOfficer |
• – – |
2006-09-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| Monath Thomas P |
Director |
– • – |
2006-09-02 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,873,563 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2006-08-22 |
4 |
B |
$3.49 |
$28,168 |
D/D |
8,000 |
4,000 |
2.39 |
- |
|
| Evans Gray C |
Director |
– • – |
2006-08-22 |
4 |
B |
$3.55 |
$177,500 |
D/D |
50,000 |
813,300 |
2.39 |
- |
|
| Hall Patricia |
Chief Accounting OfficerOffice |
• – – |
2006-05-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,514 |
|
- |
|
| Tananbaum James B |
Director |
– • – |
2006-04-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,116,637 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2006-04-11 |
4 |
B |
$4.95 |
$123,750 |
D/D |
25,000 |
763,300 |
2.39 |
- |
|
| Odonnell Denis M |
Director |
– • – |
2006-03-09 |
4 |
S |
$5.42 |
$401,920 |
D/D |
(74,155) |
221,495 |
|
- |
|
| Odonnell Denis M |
Director |
– • – |
2006-03-08 |
4 |
S |
$5.38 |
$846,812 |
D/D |
(157,400) |
221,495 |
|
- |
|
| Kelly Mitchell J |
Director |
– • – |
2006-03-03 |
4 |
S |
$5.38 |
$4,306,960 |
I/I |
(800,000) |
500 |
|
- |
|
| Kelly Mitchell J |
Director |
– • – |
2006-03-02 |
4 |
S |
$5.41 |
$5,087,000 |
I/I |
(939,601) |
500 |
|
- |
|
| Evans Gray C |
officerTitle |
– • – |
2006-01-25 |
4 |
B |
$4.00 |
$200,000 |
D/D |
50,000 |
738,300 |
2.39 |
- |
|
| Lazarus J Michael Md |
Director |
– • – |
2005-12-15 |
4 |
S |
$4.40 |
$44,000 |
D/D |
(10,000) |
11,927 |
|
- |
|
| Lazarus J Michael Md |
Director |
– • – |
2005-12-15 |
4 |
OE |
$3.75 |
$37,500 |
D/D |
10,000 |
21,927 |
|
- |
|
| Evans Gray C |
officerTitle |
– • – |
2005-12-08 |
4 |
B |
$3.50 |
$174,900 |
D/D |
50,000 |
688,300 |
2.39 |
- |
|
| Evans Gray C |
officerTitle |
– • – |
2005-12-07 |
4 |
B |
$3.60 |
$180,000 |
D/D |
50,000 |
638,300 |
2.39 |
- |
|
155 Records found
|
|
Page 5 of 7 |
|
|
